Skip to main content
Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.040
+0.110 (3.75%)
At close: Apr 28, 2026, 4:00 PM EDT
2.950
-0.090 (-2.96%)
Pre-market: Apr 29, 2026, 8:10 AM EDT

Cyclerion Therapeutics Revenue

In the year 2025, Cyclerion Therapeutics had annual revenue of $2.07M with 3.70% growth. Cyclerion Therapeutics had revenue of $1.03M in the quarter ending December 31, 2025, a decrease of -43.24%.

Revenue (ttm)
$2.07M
Revenue Growth
+3.70%
P/S Ratio
6.19
Revenue / Employee
$2,074,000
Employees
1
Market Cap
12.85M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.07M74.00K3.70%
Dec 31, 20242.00M--
Dec 31, 2023---
Dec 31, 2022297.00K-3.65M-92.47%
Dec 31, 20213.94M1.65M71.69%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CYCN News

More News